Reglan / Metoclopramide

This Reglan lawsuit was filed in Louisiana, and it alleges that Wyeth purposely concealed the side effects of long term usage of Reglan or Metoclopramide.

35. Defendant WYETH and its predecessors in interest had actual knowledge, through their own studies and studies by independent investigators, that doctors frequently prescribed Reglan/metoclopramide for long-term use that was not safe for patients. Defendant WYETH and its predecessors in interest had actual knowledge, through their own studies and studies by independent investigators, that nearly one-third of all patients who used Reglan/metoclopramide received it on doctor's prescriptions for 12 months or longer, rather than 12 weeks or less. Defendant WYETH also had actual knowledge, through research by independent investigators, that the risk of tardive dyskinesia and other extrapyramidal side effects of Reglan/metoclopramide in patients who receive the drug for 12 weeks or longer is approximately 100 times greater than disclosed in WYETH's package insert for Reglan and the Physician's Desk Reference monograph for Reglan brand metoclopramide. Defendant WYETH also knew, or through the exercise of reasonable care should have known, that many patients who use Reglan/metoclopramide are not able to effectively metabolize Reglan/metoclopramide and that as a foreseeable consequence of their inability to effectively metabolize Reglan/metoclopramide, those patients have a greater risk of developing serious and permanent injuries. Defendant WYETH failed to disclose this information to the medical community and failed to adequately disclose this information to the generic pharmaceutical industry. Defendant WYETH was aware that its failure to disclose this information to the medical community and its failure to disclose it to the generic pharmaceutical industry would probably result in serious injury to patients who were prescribed Reglan/metoclopramide by a physician who was not aware of this information. By failing to disclose this information to the medical community and the generic pharmaceutical industry, Defendant WYETH acted in willful and wanton disregard of the rights of persons in the Plaintiff Patricia Tarver's class, and this conduct caused serious injury to the Plaintiffs.

Please contact me if you think you’ve developed a movement disorder after taking Reglan or Metoclopramide for longer than 12 weeks.  I know several attorneys who handle these cases and perhaps one of them can help you.


Continue Reading Reglan Lawsuit Filed in Louisiana Against Wyeth

This document was produced in a Reglan (Metoclopramide) lawsuit.  It found that 1 in 500 people who use Reglan or Metoclopramide may develop movement disorders.  The FDA now believes that figure is closer to one in five.


Continue Reading FDA Review of Movement Disorders Caused By Reglan or Metoclopramide

Here’s a relatively unusual motion filed by the pharmaceutical company Wyeth.  In the motion, Wyeth admits that Reglan & Metoclopramide cause Tardive Dyskinesia, and admits that Reglan or Metoclopramide probably caused the plaintiff’s Tardive Dyskinesia.  Wyeth just wants to exclude a portion of an expert’s testimony regarding the adequacy of the Reglan warning label.

INTRODUCTION

Hal Morgenstern filed this affidavit in a Metoclopramide lawsuit that alleges a woman developed Tardive Dyskinesia after long term use of Metoclopramide (generic Reglan.)  He filed this affidavit because the Reglan attorneys for Wyeth asked to court to exclude Morgenstern’s testimony on the grounds that it was scientifically unreliable under what is known as the Daubert standard.

If you think you might have a Reglan lawsuit, contact me and I’ll put you in touch with an attorney who will work with you to determine if you have a case, and will work to find expert witnesses that can meet the Daubert standard.


Continue Reading Affidavit of Hal Morgenstern, Ph.D., in a Metoclopramide Lawsuit

Earlier, I posted the second brief filed by Gladys Mensing in her Metoclopramide lawsuit.  Here’s the opening brief.  It gives an even better overview of the history of Metaclopramide litigation and the link between Tardive Dyskinesia and Metoclopramide.  Metoclopramide is of course the generic version of the prescription drug Reglan.

There are many lawsuits in state and federal court filed on behalf of people who acquired movement disorders such as Tardive Dyskinesia and Tardive Dystopia after using Reglan or Metoclopramide for long periods of time.  If you think you may have a movement disorder, and you’ve been using Reglan or Metoclopramide for longer than 12 weeks, contact me and I’ll put you in touch with a Reglan attorney who will investigate whether you may have a potential Metoclopramide lawsuit.


Continue Reading Plaintiff’s Opening Brief in Reglan Lawsuit Appeal

The following brief, filed in the 8th Circuit on behalf of Gladys Mensing gives a great deal of history both of Reglan (Metoclopramide) and of why lawsuits against Metoclopramide manufacturers shouldn’t be preempted.  It’s not a light read, but it’s a good one.


Continue Reading Plaintiff’s Appellate Brief in Reglan Lawsuit

The following lawsuit, filed against Teva (the maker of Metoclopramide, a generic form of Reglan) and Wal-Mart, alleges that extended use of Metoclopramide causes Tardive Dyskinesia.

If you think you have a movement disorder and you’re taking Reglan or Metoclopramide, why not contact me to have me put you in touch with a Reglan attorney who will investigate your claim?


Continue Reading Lawsuit Against Teva and Wal-Mart Alleges that Metoclopramide Causes Tardive Dyskinisia

The following expert report from Willett v. Teva explains the link between use of Reglan (or Metoclopramide) and movement disorders such as Tardive Dyskinesia.


Continue Reading Expert Report Explains Link Between Movement Disorder Tardive Dyskinesia and Reglan (Metoclopramide)

The following expert report from Swicegood v. Pliva, Inc. explains how Metoclopramide (generic Reglan) can cause movement disorders, such as Tardive Dystonia and Tardive Dyskinesia.

I noticed that Robert Gale is mentioned here as well.  He’s the inventor of the Duragesic fentanyl patch; I’m not yet sure what involvement he has with Reglan / Metaclopramide.


Continue Reading Expert Report in Metoclopramide Lawsuit